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INFECTIOUS DISEASE/ORIGINAL RESEARCH

The Rapid Evaluation of COVID-19 Vaccination
in Emergency Departments for Underserved
Patients Study
Robert M. Rodriguez, MD*; Jesus R. Torres, MD, MPH; Anna Marie Chang, MD, MSCE; Adrianne N. Haggins, MD, MS;
Stephanie A. Eucker, MD, PhD; Kelli N. O’Laughlin, MD, MPH; Erik Anderson, MD; Daniel G. Miller, MD; R. Gentry Wilkerson, MD;
Martina Caldwell, MD, MS; Stephen C. Lim, MD; Ali S. Raja, MD, MPH; Brigitte M. Baumann, MD, MSCE; Joseph Graterol, MD;
Vidya Eswaran, MD; Brian Chinnock, MD; The REVVED UP Investigators
*Corresponding Author. E-mail: robert.rodriguez@ucsf.edu.

Study objective: Emergency departments (EDs) often serve vulnerable populations who may lack primary care and have suffered
disproportionate COVID-19 pandemic effects. Comparing patients having and lacking a regular source of medical care and other
ED patient characteristics, we assessed COVID-19 vaccine hesitancy, reasons for not wanting the vaccine, perceived access to
vaccine sites, and willingness to get the vaccine as part of ED care.
Methods: This was a cross-sectional survey conducted from December 10, 2020, to March 7, 2021, at 15 safety net US EDs.
Primary outcomes were COVID-19 vaccine hesitancy, reasons for vaccine hesitancy, and sites (including EDs) for potential COVID19 vaccine receipt.
Results: Of 2,575 patients approached, 2,301 (89.4%) participated. Of the 18.4% of respondents who lacked a regular source of
medical care, 65% used the ED as their usual source of health care. The overall rate of vaccine hesitancy was 39%; the range among the
15 sites was 28% to 58%. Respondents who lacked a regular source of medical care were more commonly vaccine hesitant than those
who had a regular source of medical care (47% versus 38%, 9% difference, 95% conﬁdence interval 4% to 14%). Other characteristics
associated with greater vaccine hesitancy were younger age, female sex, Black race, Latinx ethnicity, and not having received an inﬂuenza
vaccine in the past 5 years. Of the 61% who would accept a COVID-19 vaccine, 21% stated that they lacked a primary physician or clinic at
which to receive it; the vast majority (95%) of these respondents would accept the COVID-19 vaccine as part of their care in the ED.
Conclusion: ED patients who lack a regular source of medical care are particularly hesitant regarding COVID-19 vaccination. Most
COVID-19 vaccine acceptors would accept it as part of their care in the ED. EDs may play pivotal roles in COVID-19 vaccine
messaging and delivery to highly vulnerable populations. [Ann Emerg Med. 2021;-:1-9.]
Please see page XX for the Editor’s Capsule Summary of this article.
0196-0644/$-see front matter
Copyright © 2021 by the American College of Emergency Physicians.
https://doi.org/10.1016/j.annemergmed.2021.05.026

INTRODUCTION
Background
The greatest public health crisis of the past century,
the spread of SARS-CoV-2 and the resulting COVID19 pandemic has led to more than 500,000 deaths in
the United States as of February 23, 2021.1 While
community lockdowns, social distancing, contact
tracing, and mask wearing have had varied success in
stemming the spread of COVID-19, adherence to these
interventions has waned over time, and these measures
are essentially bridges to the ultimate mitigation
measure—broad population COVID-19
immunization.2-6
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The strength of immunization for pandemic mitigation
is predicated on broad acceptance and administration of
COVID-19 vaccines to a majority of the population. To
achieve herd immunity from COVID-19 infection, experts
have estimated that approximately 67% to 90% of the
population must be immune (by either vaccination or
natural infection).7,8 With approximately one third of the
population saying that they will not accept a COVID-19
vaccine, hesitancy is a major barrier to reaching this target
in the United States.9-16 The major limitation of prior
investigations of COVID-19 vaccine hesitancy is that they
have been primarily conducted online or by telephone,
sampling methods that often miss medically underserved or
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Editor’s Capsule Summary

What is already known on this topic
Improving COVID-19 vaccination access during care
may enhance personal and collective immunity.
What question this study addressed
What could be acceptance and hesitancy concerns for
COVID-19 vaccinations if offered to emergency
department (ED) patients already seeking care?
What this study adds to our knowledge
After receiving 2,301 survey responses (89.4% of all
approached) at 15 safety net hospitals over 3 months
starting December 2020, 65% stated they used the
ED as a regular care source and 39% reported
hesitancy concerns, with varying factors altering that
observation in subgroups.
How this is relevant to clinical practice
While EDs are a potential vaccination resource site,
many patient factors will likely dampen the impact of
ED-based vaccination programs.

disadvantaged populations who may be at the greatest risk
from COVID-19 infection.17-19 They also may not reﬂect
the attitudes of patients during true, in-person health care
encounters, when they might actually receive a vaccine.
The emergency department (ED) has been commonly
described by policymakers as “the safety net of the safety
net.”20 With approximately 140 million visits in the
United States annually, EDs serve as the primary (and often
only) health care access point for up to one ﬁfth of the
population, including a number of vulnerable
groups—immigrants, persons experiencing homelessness,
the impoverished, and the uninsured, many of whom fall
into high-risk categories for poor outcomes from COVID19 infection.21-31 Minorities, especially Blacks and Latinos
who have suffered disproportionate morbidity and
mortality during the pandemic, also receive high amounts
of primary health care through EDs.21-28
Importance and Goals of This Investigation
The overall premise underlying this research is that
efforts toward vaccination-based herd immunity,
prevention of disease in high-risk, vulnerable groups, and
equitable distribution of the COVID-19 vaccine must go
where vulnerable individuals go for care and consider EDbased vaccine messaging and administration
programs—analogous to other programs pioneered in the
2 Annals of Emergency Medicine

early 1990s in which EDs provide inﬂuenza and
pneumococcal vaccines.32-37 In this in-person survey study
of patients conducted in a real-world, health care safety net
setting (patient visits to 15 EDs across the United States),
we assessed the need for such ED-based programs.
Comparing patients who have and lack a regular source of
medical care and delineating a group that uses the ED as
their usual source of care, we assessed COVID-19 vaccine
hesitancy rates, reasons for vaccine hesitancy, and
willingness to get the COVID-19 vaccine as part of ED
care.
MATERIALS AND METHODS
Design and Setting
From December 20, 2020, to March 7, 2021, we
conducted this cross-sectional survey study of ED patients
during their visits to 15 safety net EDs in 14 US cities (San
Francisco, CA; Oakland, CA; Fresno, CA; Sylmar, CA;
Seattle, WA; Iowa City, IA; Detroit, MI; Ann Arbor, MI;
New Orleans, LA; Philadelphia, PA; Durham, NC;
Baltimore, MD; Camden, NJ; and Boston, MA). The
median annual number of visits to these EDs was 77,000
(range 45,000 to 120,000). We obtained institutional
review board approval to conduct this survey study by
scripted verbal consent at all study sites. We followed the
Strengthening the Reporting of Observational Studies in
Epidemiology guidelines.
Survey Instrument Development
The lead investigator reviewed existing literature on
vaccine hesitancy and consulted with experts in survey
development at the University of California San
Francisco (UCSF) to generate an initial survey template.
Questions about vaccine hesitancy were adapted from
previously published instruments.9-16 We reviewed this
initial template with a focus group of 8 community
participants from the UCSF COVID-19 Patient
Community Advisory Board to gain recommendations
about survey questions’ relevance, wording, cultural
sensitivity, comprehension, and length; we also sought
input on overall study procedures in terms of survey
location, timing, languages needed, and delivery.
Investigators on the research team reviewed and edited
the template according to focus group recommendations,
and we again presented this second iteration to the
Patient Community Advisory Board for ﬁnal review and
editing. We pilot tested the ﬁnal instrument on 6 ED
patients at the core site and found excellent
comprehension and response consistency (Appendix E1,
available at http://www.annemergmed.com).
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Selection of Participants: Inclusions, Exclusions, and
Survey Administration
Because of differing times of institutional review board
approval receipt, the sites began enrollment at different
times from December 10, 2020, to January 21, 2021; each
site targeted enrollment of 150 patients over a 5-week
period. We enrolled adult patients (>18 years of age) using
convenience sampling according to the availability of study
personnel (typically 4- to 6-hour time blocks), excluding
patients with any of the following characteristics: major
trauma, transfer from another facility, incarceration,
psychiatric hold, intoxication, altered mental status, critical
illness, or temporary visit from another country. Research
personnel reviewed triage logs and ED electronic health
record census boards to identify potentially eligible
participants. At 11 sites, all surveys were conducted in
person; given constraints for in-person surveys during the
pandemic, 3 sites used a second mechanism of calling into
telephones in ED patient rooms to conduct the survey, and
1 site called patients immediately after ED discharge. After
scripted verbal consent, research personnel read survey
questions to participants directly from data collection forms
and tablets in their preferred language. Before questions
about COVID-19 vaccines, we presented this statement:
“It is likely that one or more vaccines for COVID-19 will
be available in the spring or summer of next year. While
these vaccines cannot assure complete protection, they will
decrease your and your family members’ likelihood of
becoming infected with COVID-19. These vaccines will
likely be provided free of charge.”

Deﬁnitions and Primary Outcomes
Vaccine hesitancy was deﬁned as a “no” or “unsure”
response to the question, “Would you accept the COVID19 vaccine when it becomes available?” After survey
completion, we categorized participants into either the
“have regular source of medical care” or the “lack regular
source of medical care” group by their response to this yes/
no question: “Do you have a regular clinic or doctor for
medical care?” We further delineated patients who used the
ED as their usual source of care by their answers to this
multiple-choice question: “If NO to regular doctor, where
do you usually go when you are sick or need medical
advice?”
Our primary outcomes were responses to key survey
questions regarding acceptance versus nonacceptance
(hesitancy) of the COVID-19 vaccine, reasons for vaccine
hesitancy, sites for potential receipt of the COVID-19
vaccine, and acceptability of the COVID-19 vaccine as part
of care in the ED.
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Data Analysis
We summarized patient characteristics as raw counts and
frequency percentages and aggregate key survey question
responses as percentages with 95% conﬁdence intervals
(CIs), excluding nonresponses to individual questions in
proportion denominators. To assess differences in vaccine
hesitancy between groups (have versus lack regular source
of medical care, male verses female sex, Black versus White
race, Latinx versus White/nonLatinx ethnicity, homeless
versus housed, and having received an inﬂuenza vaccine in
the past 5 years versus not having received an inﬂuenza
vaccine), we compared 95% CIs around differences in
proportions. We used a 2-sample Wilcoxon rank sum test
to test for differences in vaccine hesitancy for the
nonnormally distributed age characteristic. We further
stratiﬁed vaccine hesitancy by the 15 sites, along with data
regarding having a regular source of medical care and ED
usual source of care for context. We stratiﬁed reasons for
vaccine hesitancy according to whether respondents had a
regular source of medical care.
In our a priori sample size calculation, we determined
that we would need to enroll 2,144 patients to attain a 2%
margin of error around point estimates of primary outcome
questions; therefore, we sought 150 respondents at each of
the 15 sites. We managed data using REDCap38 and
conducted analyses using Stata v16.1 (StataCorp LLC,
College Station, TX).
RESULTS
Of 2,575 patients approached, 2,301 (89.4%)
participated; 339 (14.7%) had been previously diagnosed
with COVID-19. Most respondents (81%) had primary
care doctors or clinics. Of the 19% who lacked primary
care, 65% used the ED as their usual source of health care
and 26% went to an urgent care center or clinic. Compared
to patients who had primary care, patients who did not
have primary care were younger (median age 36 versus 52
years, P<.001), were more often men (67% versus 47%,
P<.001), were more commonly Latinx (37% versus 21%,
P<.001), were more commonly homeless (10% versus 2%,
P<.001), were more commonly uninsured (38% versus
7%, P<.001), less commonly spoke English as their
primary language (71% versus 83%, P<.001), and had less
commonly received an inﬂuenza vaccine in the past 5 years
(46% versus 74%, P<.001).
COVID-19 Vaccine Hesitancy
The overall rate of vaccine hesitancy was 39% (95% CI
37% to 41%). Respondents who lacked a regular source of
medical care were more commonly vaccine hesitant than
Annals of Emergency Medicine 3
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Table 1. Vaccine hesitancy stratiﬁed by participant characteristics.
Characteristic

All (2,301)

Age in years, median (IQR)

48 (34–61)

52 (38–64)

40 (29–55)

N (%)

N [%, 95% CI] or N (%)

N [%, 95% CI] or N (%)
384 [33%, 95% CI 31–36]

Sex

Will Accept Vaccine (1,381, 60%)

Vaccine Hesitant (900, 39%)

Male

1,147 (50)

761 [66%, 95% CI 64–69]

Female

1,131 (49)

618 [55%, 95% CI 52–58]

512 [45%, 95% CI 42–48]

1,859 (81)

1,159 [62%, 95% CI 60–65]

698 [38%, 95% CI 35–40]

Lack regular source of medical care

424 (18)

227 [54%, 95% CI 49–58]

197 [46%; 95% CI 42–51]

ED usual source of care

275 (12)

150 [55%, 95% CI 49–61]

125 [45%, 95% CI 40–52]
376 [54%, 95% CI 50–57]

Have a regular source of medical care

Race/Ethnicity
Black

700 (30)

324 [46%, 95% CI 43–50]

Asian

106 (5)

74 (70)

32 (30)

Latinx

538 (23)

326 [61%, 95% CI 56–65]

209 [39%, 95% CI 35–43]

Middle Eastern

28 (1)

14 (50)

14 (50)

Native American

27 (1)

13 (48)

14 (52)

Native Hawaiian/Paciﬁc Islander

8 (0.3)

6 (75)

2 (25)

900 (39)

631 [70%, 95% CI 67–73]

268 [30%, 95% CI 27–33]

White (nonLatinx)
Other

70 (3)

42 (60)

28 (40)

Homeless

84 (4)

53 [63%, 95% CI 52–73]

31 [37%, 95% CI 27–48]

2,202 (96)

1,332 [60%, 95% CI 58–63]

867 [39%, 95% CI 37–41]

Housed
Health insurance types
Private

871 (38)

578 (66)

293 (34)

Medicaid

653 (28)

350 (54)

302 (46)

Medicare

539 (24)

372 (69)

167 (31)

ACA/ObamaCare

108 (5)

65 (60)

43 (40)

Kaiser Permanente

22 (1)

12 (55)

10 (45)

Veterans administration

17 (0.7)

8 (47)

9 (53)

44 (2)

23 (52)

21 (48)

286 (12)

164 [57%, 95% CI 51–63]

121 [42%, 95% CI 37–48]

English

1,851 (80)

1,095 (59)

754 (41)

Spanish

344 (15)

235 (68)

108 (31)

Cantonese/Mandarin

16 (0.7)

12 (75)

4 (25)

79 (3)

47 (59)

32 (41)

Yes

1,561 (68)

1,076 [69%, 95% CI 67–71]

483 [31%, 95% CI 29–33]

No

645 (28)

268 [42%, 95% CI 38–46]

376 [58%, 95% CI 54–62]

Yes/some

1,529 (66)

1,143 (75)

385 (25)

No/unsure

693 (30)

201 (29)

492 (71)

Other
Uninsured
Primary language

Other
Have you had an inﬂuenza vaccine in the last 5 years?

Would your family accept a COVID-19 vaccine?

IQR, interquartile range; ACA, Affordable Care Act.

those who had a regular source of medical care (47% versus
38%, 9% difference, 95% CI 4% to 14%); likewise, the
subgroup of respondents who reported the ED as their
usual source of care was more vaccine hesitant than those
who had a regular source of medical care (46% versus 38%,
difference 8%, 95% CI 2% to 14%). Other characteristics
4 Annals of Emergency Medicine

associated with greater vaccine hesitancy were younger age
(median 40 years versus 52 years, P<.0001), female sex
(45% versus 33%, difference 12%, 95% CI 8% to 16%),
Black race (54% versus 30%, difference 24%, 95% CI
19% to 29%), Latinx ethnicity (39% versus 30%,
difference 9%, 95% CI 4% to 14%), and not having
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Figure. Vaccine hesitancy, lack of regular source of medical care, and ED as usual source of medical care, stratiﬁed by 15 study sites.

received an inﬂuenza vaccine in the past 5 years (58%
versus 31%, difference 27%, 95% CI 23% to 32%).
Homelessness and uninsured status were not associated
with greater vaccine hesitancy. Fewer vaccine-hesitant
respondents reported that some or all of their family
members would accept the COVID-19 vaccine if it was
offered to them (29% versus 75%, 46% difference, 95%
CI 42% to 50%) (Table 1).

The lowest rate of vaccine hesitancy (28%) was at the
UCSF Parnassus ED (San Francisco, CA), which also had
the lowest rate of patients who reported the ED as their
usual source of care. At the county hospital ED in the
same city, Zuckerberg San Francisco General, the
hesitancy rate was 40%. The highest vaccine hesitancy
rate (58%) was at the Cooper University Hospital site
(Camden, NJ) (Figure).

Table 2. Declared reasons for vaccine hesitancy.
What are Reasons for not Accepting a COVID-19 Vaccine?
n (%)

All N[900

Have Primary Care/
Clinic N[698

Lack Primary Care/
Clinic N[197

Have concerns about side effects and safety
Need more information about the vaccine

582 (65%)

470 (67%)

110 (56%)

421 (47%)

324 (46%)

94 (48%)

Heard media stories that gave me doubt about vaccines

218 (24%)

167 (24%)

50 (25%)

Don’t believe the vaccine will work

111 (12%)

81 (12%)

29 (15%)

Not worried about getting COVID-19 infection

86 (10%)

55 (8%)

31 (16%)

Already had COVID-19 infection

34 (4%)

25 (4%)

9 (5%)

180 (20%)

136 (20%)

44 (22%)

Other
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Reasons for Vaccine Hesitancy
The 3 primary reasons for vaccine hesitancy were similar
for those with and without a source of regular medical care:
concerns about side effects and safety (65%), need for more
information (47%), and having heard stories in the media
or online (24%). The fourth most common reason for
respondents who had primary care was “don’t believe the
vaccine will work”; in respondents who lacked primary
care, the fourth most common reason was “not worried
about getting COVID-19 infection” (Table 2).
Sites for Receipt of COVID-19 Vaccine
Of the 1,392 (61%) respondents who stated they would
accept the COVID-19 vaccine, 1,100 (79%) had a primary
clinic at which to get it. The vast majority of all vaccine
acceptors (93%) and patients who reported the ED as their
usual source of care (95%) reported that they would accept
the COVID-19 vaccine as part of their care in the ED.
LIMITATIONS
Our study is subject to the limitations inherent to
survey-type research—most notably, various elements of
spectrum bias. All of the sites in this study were urban EDs
afﬁliated with academic medical institutions; our ﬁndings
may not apply to rural, nonacademic ED populations. We
only surveyed people who actually came to the EDs; people
who have the greatest distrust of health care and highest
vaccine hesitancy may be less likely to come to an ED (or
any health care facility) for care. We had numerous
exclusion criteria for this study, including critical illness,
major trauma, and altered mental status, which limit the
applicability of our ﬁndings to the fully alert and less-ill
segment of the ED population. Nevertheless, most of these
excluded patients would be unable to meaningfully
participate in COVID-19 vaccine messaging programs;
they would likewise be ineligible to receive COVID-19
vaccines in the ED. In other words, our sampling precisely
reﬂects the population that would practically beneﬁt from
ED-based COVID-19 interventions.
Although we employed best practice methods for survey
development and standard questions to assess vaccine
hesitancy, our instrument was not independently validated.
Despite using neutral tones and reading questions directly
from survey instruments, we may have induced a social
desirability bias in participant responses, which would
likely inﬂate rates of vaccine acceptance.
DISCUSSION
Conducted in a real-world, health care safety net setting,
the Rapid Evaluation of COVID-19 Vaccination in EDs for
6 Annals of Emergency Medicine

Underserved Patients study deﬁnes populations who are
distinctly vulnerable to vaccine hesitancy and poor health care
access for receipt of vaccines—those who lack a regular source
of medical care and whose primary health care access is
through EDs. Nearly half of these groups were COVID-19vaccine hesitant, and over one ﬁfth of those who would
accept a COVID-19 vaccine reported that they did not have
a clinic or physician they could visit to readily get it. Notably,
two thirds of patients who lacked a regular source of medical
care and used the ED as a usual source of care in our EDs
were Black or Latinx, racial and ethnic groups that have
experienced disproportionately high morbidity and mortality
during the COVID-19 pandemic. Supporting the notion
that these populations have traditionally suffered other
vaccine-related health care disparities is our ﬁnding that less
than half had received an inﬂuenza vaccine in the past 5 years.
Toward herd immunity and greater acceptance and
delivery of the COVID-19 vaccine in vulnerable
populations, our research highlights an ideal site for
interventions—the ED. Homelessness, poverty, language
difﬁculties, and other factors may render traditional
internet-, television-, radio-, and social media-based vaccine
hesitancy messaging platforms ineffective for these groups.
Even in those who do have access to media, messages that
are directed at socioeconomically dissimilar populations
may not resonate with them or convince them to accept the
COVID-19 vaccine. Side effects and misinformation were
commonly reported concerns among vaccine-hesitant
responders in our study, and approximately half stated that
they wanted more information about the vaccines.
Considering that nearly two thirds of respondents who
lacked a regular source of medical care stated that their
usual care occurred in EDs, ED health care personnel may
become their de facto primary care providers and
consequently serve as their best trusted messengers to
promote COVID-19 vaccine acceptance.
Similarly, the ED has great potential to overcome the
other barrier to COVID-19 vaccination for these
groups—perceived lack of a health care site for receipt of
the vaccine. Because most sites in this study conducted
their surveys when vaccines were available only to health
care workers and nursing home residents, we did not ask
questions about attempts to obtain the COVID-19
vaccine. Nevertheless, the vast majority of respondents who
had received an inﬂuenza vaccine had received it at their
primary care clinic, and many vaccine acceptors reported
not having a clinic at which to get the COVID-19 vaccine.
Furthermore, current internet-based signups and drivethrough mass vaccinations may not be feasible mechanisms
for COVID-19 vaccination of many vulnerable populations
who lack internet access and cars.39-41 In addition to
Volume

-,

no.

-

:

-

2021

Rodriguez et al

COVID-19 Prevention in Underserved Emergency Department Populations

messaging about safety and efﬁcacy of the vaccine, ED
providers can inform patients where, when, and how they
can get the COVID-19 vaccine, perhaps assisting them in
scheduling appointments prior to discharge from the ED.
An even more ambitious role for the ED is as a site for
actual COVID-19 vaccine administration, analogous to the
current practice in many EDs of providing inﬂuenza vaccines
to their patients as part of their ED care for other problems.
Almost all vaccine acceptors, including 95% of patients who
reported the ED as their usual source of care, stated that they
would accept a COVID-19 vaccine as part of their ED care.
Some EDs have already adopted the practice of using “endof-the-day” leftover supplies of vaccines from their afﬁliated
hospital vaccine sites.42 In terms of practicality of broader
ED-based immunization programs, single-dose (Johnson
and Johnson) vaccines would alleviate the problems of
scheduling return visits for a second COVID-19 injection.43
One-shot, ED-based COVID-19 vaccine delivery programs
may be particularly useful for homeless persons, many of
whom derive most of their health care and, at times,
subsistence needs in EDs, as well as for others who do not
have pre-established hospital connections.31,44,45
Undocumented immigrants, many of whom fear discovery
and deportation when providing personal information,46
would also beneﬁt from a limited, one-time interaction for
COVID-19 vaccination in the ED. Although feasibility
constraints and interference with critical ED workﬂow
preclude converting EDs into mass vaccination sites for the
general population, opportunistically vaccinating patients
while they are already in EDs for other reasons could
leverage EDs’ great visit volumes (139 million visits in
201721) and lead to substantially greater COVID-19 vaccine
delivery to vulnerable populations whose only health care
occurs there. In a survey that our team conducted with the
American College of Emergency Physicians, a majority of
ED medical directors indicated support for such adjunctive
ED-based COVID-19 immunization programs.47
As compared to other online- and telephone-based
investigations of the national landscape regarding vaccine
hesitancy, our high-response-rate, in-person survey of all
eligible ED patients has several notable advantages. First, it
reduces the sampling bias inherent in other methods,
allowing for the potential inclusion of those who do not
have internet access and those who do not respond to
telephone surveys. Second, views expressed in true health
care environments are likely to represent true health care
decisions more accurately than those expressed over the
phone or through anonymous internet surveys. Finally, our
site stratiﬁcation provides granular information that may
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inform local efforts to address vaccine hesitancy at speciﬁc
institutions.
Our ﬁndings are similar to those of other surveys with
regard to the higher rates of vaccine hesitancy in Blacks and
Latinos.11-14 This vaccine hesitancy gap threatens to further
exacerbate the existing disproportionate effects of the
COVID-19 pandemic on Blacks, Latinos, and other
vulnerable communities.48-52 Despite having over twice the
age-adjusted death rates of Whites, Blacks and Latinos have
had approximately half the vaccination rates.53,54 Of the 57
million people in the United States who had received a
COVID-19 vaccine as of March 6, 2021, only 7% were
Black and 8.5% were Latinx, compared to 65.3% nonHispanic Whites.54 Given that they serve high proportions
of Blacks and Latinos, EDs are uniquely positioned to
address COVID-19 and other health care disparities. In
terms of other characteristics, younger age, female sex, and
not having previously received inﬂuenza vaccines were
powerful predictors of vaccine hesitancy, but homelessness
and uninsured status were not.
The reasons for COVID-19 vaccine hesitancy found in
our study mirror those reported in research regarding
vaccines in the setting of other infectious disease
outbreaks.55,56 In a survey conducted in Detroit during a
hepatitis A outbreak, 23% of homeless individuals reported
hesitation in receiving hepatitis A immunization, citing
safety and efﬁcacy concerns as well as mistrust of the
intentions of health care providers and vaccine
manufacturers.55 Among a predominantly Latinx population
of homeless individuals in New York City, concerns
regarding becoming ill as a result of the vaccine was the most
common reason cited for not receiving the inﬂuenza
vaccination during the 2018 to 2019 inﬂuenza season.56
In conclusion, we have identiﬁed populations—those
who lack a regular source of medical care and whose
principal health care access occurs in EDs—that are
particularly vulnerable to vaccine hesitancy and perceive
limited access to sites for receipt of the COVID-19 vaccine.
National programs for ED-based COVID-19 vaccine
messaging and vaccine delivery should be considered for
these highly vulnerable populations.
The REVVED UP Investigators: Graham Nichol, MD,
MPH, Blair A. Parry, Alaina Hunt, BA, Morgan Kelly, BS,
Breena R. Taira, MD, MPH, Michael Pham, Joshua Tiao,
MD, Kyra Lasko, Mayuri Aivale, MPH, Alex Farthing, BA,
Nicole Byl, BA, Virginia Chan, BS, Nancy Anaya, MD,
Angela H. Wong, BA, Bhanu Chadalawada, MS, Anna
Tupetz, PT, DPT.
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